Tirzepatide, a recently approved medication, is sparking significant buzz in the healthcare community as a possible treatment for both diabetes, type 2 and weight loss . This unique drug works by targeting two separate receptors, GLP-1 and GIP, leading to enhanced blood sugar levels and notable fat loss in clinical trials . While preliminary findin